Diagnosis of lysosomal storage disorders: Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker

P. J. Meikle, D. A. Brooxs, E. M. Ravenscroft, M. Yan, R. E. Williams, A. E. Jaunzems, T. K. Chataway, L. E. Karageorgos, R. C. Davey, C. D. Boulter, S. R. Carlsson, J. J. Hopwood

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Early diagnosis of lysosomal storage, disorders (LSDs), before the onset of irreversible pathologies, will be a key factor in the development of effective therapies for many of these disorders. Newborn screening offers a potential mechanism for the early detection of these disorders. From studies of both normal and LSD-affected human skin fibroblasts we identified the lysosome-associated membrane protein LAMP-1 as a potential diagnostic marker. We have developed a sensitive method for the quantification of this protein with a time-resolved fluorescence immunoassay. A soluble form of LAMP-1 was observed in plasma samples, and determination of 152 unaffected individuals gave a median value of 303 μg/L with the 5th and 95th percentile at 175 and 448 μg/L respectively. Plasma samples from 320 LSD-affected individuals representing 25 different disorders were assayed. We observed that 17 of the 25 disorder groups tested had >88% of individuals above the 95th percentile of the control population, with 12 groups having 100% above the 95th percentile. Overall, 72% of patients had LAMP-1 concentrations above the 95th percentile of the unpartitioned control population. We suggest that LAMP-1 may be a useful marker in newborn screening for LSDs.

LanguageEnglish
Pages1325-1335
Number of pages11
JournalClinical Chemistry
Volume43
Issue number8
Publication statusPublished - 19 Aug 1997
Externally publishedYes

Keywords

  • Blood spot
  • Guthrie card
  • Skin fibroblast
  • Time-resolved fluorescence immunoassay

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Meikle, P. J., Brooxs, D. A., Ravenscroft, E. M., Yan, M., Williams, R. E., Jaunzems, A. E., ... Hopwood, J. J. (1997). Diagnosis of lysosomal storage disorders: Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker. Clinical Chemistry, 43(8), 1325-1335.
Meikle, P. J. ; Brooxs, D. A. ; Ravenscroft, E. M. ; Yan, M. ; Williams, R. E. ; Jaunzems, A. E. ; Chataway, T. K. ; Karageorgos, L. E. ; Davey, R. C. ; Boulter, C. D. ; Carlsson, S. R. ; Hopwood, J. J. / Diagnosis of lysosomal storage disorders : Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker. In: Clinical Chemistry. 1997 ; Vol. 43, No. 8. pp. 1325-1335.
@article{722f50dc20cd4531ad5fdf5c8856c601,
title = "Diagnosis of lysosomal storage disorders: Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker",
abstract = "Early diagnosis of lysosomal storage, disorders (LSDs), before the onset of irreversible pathologies, will be a key factor in the development of effective therapies for many of these disorders. Newborn screening offers a potential mechanism for the early detection of these disorders. From studies of both normal and LSD-affected human skin fibroblasts we identified the lysosome-associated membrane protein LAMP-1 as a potential diagnostic marker. We have developed a sensitive method for the quantification of this protein with a time-resolved fluorescence immunoassay. A soluble form of LAMP-1 was observed in plasma samples, and determination of 152 unaffected individuals gave a median value of 303 μg/L with the 5th and 95th percentile at 175 and 448 μg/L respectively. Plasma samples from 320 LSD-affected individuals representing 25 different disorders were assayed. We observed that 17 of the 25 disorder groups tested had >88{\%} of individuals above the 95th percentile of the control population, with 12 groups having 100{\%} above the 95th percentile. Overall, 72{\%} of patients had LAMP-1 concentrations above the 95th percentile of the unpartitioned control population. We suggest that LAMP-1 may be a useful marker in newborn screening for LSDs.",
keywords = "Blood spot, Guthrie card, Skin fibroblast, Time-resolved fluorescence immunoassay",
author = "Meikle, {P. J.} and Brooxs, {D. A.} and Ravenscroft, {E. M.} and M. Yan and Williams, {R. E.} and Jaunzems, {A. E.} and Chataway, {T. K.} and Karageorgos, {L. E.} and Davey, {R. C.} and Boulter, {C. D.} and Carlsson, {S. R.} and Hopwood, {J. J.}",
year = "1997",
month = "8",
day = "19",
language = "English",
volume = "43",
pages = "1325--1335",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "8",

}

Meikle, PJ, Brooxs, DA, Ravenscroft, EM, Yan, M, Williams, RE, Jaunzems, AE, Chataway, TK, Karageorgos, LE, Davey, RC, Boulter, CD, Carlsson, SR & Hopwood, JJ 1997, 'Diagnosis of lysosomal storage disorders: Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker', Clinical Chemistry, vol. 43, no. 8, pp. 1325-1335.

Diagnosis of lysosomal storage disorders : Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker. / Meikle, P. J.; Brooxs, D. A.; Ravenscroft, E. M.; Yan, M.; Williams, R. E.; Jaunzems, A. E.; Chataway, T. K.; Karageorgos, L. E.; Davey, R. C.; Boulter, C. D.; Carlsson, S. R.; Hopwood, J. J.

In: Clinical Chemistry, Vol. 43, No. 8, 19.08.1997, p. 1325-1335.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diagnosis of lysosomal storage disorders

T2 - Clinical Chemistry

AU - Meikle, P. J.

AU - Brooxs, D. A.

AU - Ravenscroft, E. M.

AU - Yan, M.

AU - Williams, R. E.

AU - Jaunzems, A. E.

AU - Chataway, T. K.

AU - Karageorgos, L. E.

AU - Davey, R. C.

AU - Boulter, C. D.

AU - Carlsson, S. R.

AU - Hopwood, J. J.

PY - 1997/8/19

Y1 - 1997/8/19

N2 - Early diagnosis of lysosomal storage, disorders (LSDs), before the onset of irreversible pathologies, will be a key factor in the development of effective therapies for many of these disorders. Newborn screening offers a potential mechanism for the early detection of these disorders. From studies of both normal and LSD-affected human skin fibroblasts we identified the lysosome-associated membrane protein LAMP-1 as a potential diagnostic marker. We have developed a sensitive method for the quantification of this protein with a time-resolved fluorescence immunoassay. A soluble form of LAMP-1 was observed in plasma samples, and determination of 152 unaffected individuals gave a median value of 303 μg/L with the 5th and 95th percentile at 175 and 448 μg/L respectively. Plasma samples from 320 LSD-affected individuals representing 25 different disorders were assayed. We observed that 17 of the 25 disorder groups tested had >88% of individuals above the 95th percentile of the control population, with 12 groups having 100% above the 95th percentile. Overall, 72% of patients had LAMP-1 concentrations above the 95th percentile of the unpartitioned control population. We suggest that LAMP-1 may be a useful marker in newborn screening for LSDs.

AB - Early diagnosis of lysosomal storage, disorders (LSDs), before the onset of irreversible pathologies, will be a key factor in the development of effective therapies for many of these disorders. Newborn screening offers a potential mechanism for the early detection of these disorders. From studies of both normal and LSD-affected human skin fibroblasts we identified the lysosome-associated membrane protein LAMP-1 as a potential diagnostic marker. We have developed a sensitive method for the quantification of this protein with a time-resolved fluorescence immunoassay. A soluble form of LAMP-1 was observed in plasma samples, and determination of 152 unaffected individuals gave a median value of 303 μg/L with the 5th and 95th percentile at 175 and 448 μg/L respectively. Plasma samples from 320 LSD-affected individuals representing 25 different disorders were assayed. We observed that 17 of the 25 disorder groups tested had >88% of individuals above the 95th percentile of the control population, with 12 groups having 100% above the 95th percentile. Overall, 72% of patients had LAMP-1 concentrations above the 95th percentile of the unpartitioned control population. We suggest that LAMP-1 may be a useful marker in newborn screening for LSDs.

KW - Blood spot

KW - Guthrie card

KW - Skin fibroblast

KW - Time-resolved fluorescence immunoassay

UR - http://www.scopus.com/inward/record.url?scp=0030797123&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1325

EP - 1335

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 8

ER -

Meikle PJ, Brooxs DA, Ravenscroft EM, Yan M, Williams RE, Jaunzems AE et al. Diagnosis of lysosomal storage disorders: Evaluation of lysosome- associated membrane protein LAMP-I as a diagnostic marker. Clinical Chemistry. 1997 Aug 19;43(8):1325-1335.